A Gulik
Overview
Explore the profile of A Gulik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larabi M, Pages N, Pons F, Appel M, Gulik A, Schlatter J, et al.
J Antimicrob Chemother
. 2003 Dec;
53(1):81-8.
PMID: 14657087
Objectives: The aim of this study was to evaluate the toxicity of a new lipid complex formulation of amphotericin B (LC-AmB) produced by a simple process. Methods: Toxicity was evaluated...
2.
Ferezou J, Gulik A, Domingo N, Milliat F, Dedieu J, Dunel-Erb S, et al.
Nutrition
. 2001 Dec;
17(11-12):930-3.
PMID: 11744343
Objectives: Parenteral fat emulsions contain two populations of particles: artificial chylomicrons rich in triacylglycerols (TAG), and liposomes (bilayer of phospholipids [PL] enveloping an aqueous phase). Centrifugation permits isolating the liposomes...
3.
Mosqueira V, Legrand P, Gulik A, Bourdon O, Gref R, Labarre D, et al.
Biomaterials
. 2001 Sep;
22(22):2967-79.
PMID: 11575471
The aim of our work was to examine the relationship between modifications of the surface of nanocapsules (NC) by adsorption or covalent grafting of poly(ethylene oxide) (PEG), and changes in...
4.
Lambert G, Fattal E, Gulik A, Couvreur P
Int J Pharm
. 2001 Apr;
214(1-2):13-6.
PMID: 11282229
Antisense oligonucleotides (ODNs) with base sequences complementary to a specific RNA can, after binding to intracellular mRNA, selectively modulate the expression of a gene. However, these molecules are poorly stable...
5.
Lambert G, Fattal E, Gulik A, Couvreur P
Pharm Res
. 2000 Aug;
17(6):707-14.
PMID: 10955845
Purpose: The goal of the present paper was to encapsulate oligonucleotides in a new particulate carrier in order to protect them from enzymatic degradation. Methods: Nanocapsules with an aqueous core...
6.
Morel J, Dhahan N, Bayol P, Cerqueira F, Rigault D, Merah Z, et al.
Biochim Biophys Acta
. 1999 Nov;
1472(3):413-30.
PMID: 10564756
Myosin subfragment 1 (S1) forms dimers in the presence of Mg(2+) or MgADP or MgATP. The entire myosin molecule forms head-head dimers in the presence of MgATP. The angle between...
7.
Peracchia M, Harnisch S, Gulik A, Dedieu J, Desmaele D, dAngelo J, et al.
Biomaterials
. 1999 Jul;
20(14):1269-75.
PMID: 10403044
The in vitro protein-rejecting properties of PEG-coated polyalkylcyanoacrylate (PACA) nanoparticles were for the first time visualized after freeze-fracture of the nanoparticles pre-incubated with fibrinogen as a model blood protein. The...
8.
Clary L, Gadras C, Greiner J, Rolland J, Santaella C, Vierling P, et al.
Chem Phys Lipids
. 1999 Jul;
99(2):125-37.
PMID: 10390836
This paper describes the morphological characterization, by freeze-fracture electron microscopy, and the thermotropic phase behavior, by differential scanning calorimetry and/or X-ray scattering, of aqueous dispersions of various hydroxylated and galactosylated...
9.
Rogalska E, Rogalski M, Gulik-Krzywicki T, Gulik A, Chipot C
Proc Natl Acad Sci U S A
. 1999 Jun;
96(12):6577-80.
PMID: 10359753
In saturated solutions of some di- and trichlorophenols, structures with complex morphologies, consisting of thin, transparent sheets often coiling into helices and ultimately twisting into filaments, were observed under the...
10.
Rojas J, Leo E, Pecquet S, Couvreur P, Gulik A, Fattal E
Pharm Res
. 1999 Apr;
16(2):255-60.
PMID: 10100311
Purpose: The goal of the present paper was to investigate the role of a surfactant, Tween 20, in the modulation of the entrapment and release of beta-lactoglobulin (BLG) from poly...